Clinical Trials Sponsored by Italian Diabetes Foundation

Total 537 results

Ospedale San Raffaele
Italian Diabetes Foundation

Completed

Minimal Islet Transplant at Diabetes Onset (MITO)

Diabetes Mellitus, Type 1

Italy
Emanuele Bosi
Italian Diabetes Foundation

Completed

Universal Capillary Screening for Chronic Autoimmune, Metabolic and Cardiovascular Diseases: Feasibility and Acceptability Pilot Study. (UNISCREEN)

Autoimmune Diseases | Cardiovascular Risk Factors

Italy
Piemonti Lorenzo
Italian Diabetes Foundation

Completed

Monotherapy With Rapamycin in Long-standing Type 1 Diabetes (MONORAPA)

Diabetes Mellitus, Type 1

Italy
Diabetes Foundation, India

Not yet recruiting

Vitamin D Supplementation on Surrogate Markers of Atherosclerosis

Atherosclerosis
Asia Diabetes Foundation

Completed

Using a Diabetic Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT) (DKD-TMT)

Diabetic Kidney Disease

Taiwan, China, Hong Kong, Korea, Republic of, Malaysia, Thailand, Vietnam
Asia Diabetes Foundation

Completed

Establishing a Diabetes Registry Using the JADE-DIAMOND Electronic Portal (CN001) (China-JD)

Diabetes

Hong Kong
Diabetes Foundation, India

Completed

Almond Intervention in Type 2 Diabetes Mellitus

Cardiovascular Diseases

India
Diabetes Foundation, India

Not yet recruiting

High Protein Diet on Transcriptomic, Metabolomics, Hepatic and Pancreatic Fat Anatomy and Physiology in Asian Indians With Pre-diabetes

Pre-diabetes
Diabetes Foundation, India

Recruiting

Vitamin D Supplementation on Surrogate Markers of Ageing, Ageing Genes, Glycemic and Metabolic Markers in North India

PreDiabetes | Aging | Vitamin D Supplementation

India
Diabetes Foundation, India

Completed

High Protein Atkin's Complete (Lacto) VEgetaRian Diet (PACER) and Weight Loss (PACER)

Obesity

India
Diabetes Foundation, India

Completed

Phenotypic and Genetic Correlates of Diabetes (Non-Type 1) in Young Non-Obese Asian Indians in North India and A Study to Evaluate the Efficacy of Sitagliptin (DPP-4 Inhibitor) in a Sub-group of the Study Population

Diabetes Mellitus, Type 2

India
Asia Diabetes Foundation

Completed

Effectiveness of a Treat-to-target Clinic Led by a Nurse Consultants

Diabetes

Hong Kong
Diabetes Foundation, India

Completed

Protein Supplementation and Weight Loss

Obesity

India
Asia Diabetes Foundation

Completed

PLATINUM Program: A Feasibility Study on a Train-the-trainer Course on Peer Support for People With Type 2 Diabetes (PLATINUM)

Diabetes

Hong Kong
Asia Diabetes Foundation

Completed

Comparing the Effect of Structured Care Versus Usual Care in Type 2 Diabetes Patients Across the Asia Pacific Region (AP-JD)

Diabetes

Hong Kong
Asia Diabetes Foundation

Unknown

Evaluation of Morbidities, Endpoints and Reaching Targets in Diabetic Patients Managed by a Diabetes Specialist Team (EMERALD)

Obesity | Diabetes

Hong Kong
Asia Diabetes Foundation

Unknown

An Evaluation of the Effectiveness and Acceptability of Delivering Structured Care in Chinese Type 2 Diabetic Patients (JADE-JA)

Diabetes

China
Medtronic Diabetes
Juvenile Diabetes Research Foundation

Completed

Effect of Closed Loop Glucose Control on Exercise-Associated Hypoglycemia (ePID-03)

Type 1 Diabetes Mellitus

United States
Diabetes Foundation, India
National Diabetes Obesity and Cholesterol Foundation

Recruiting

Assessment of Hand Grip Strength Using Jamar Dynamometer

Type2diabetes

India
Diabetes Foundation, India
National Diabetes Obesity and Cholesterol Foundation

Completed

Effect of SGLT-2 Inhibitors in Patients With T2DM and Moderate to Severe Liver Fibrosis

Type2diabetes

India
Diabetes Foundation, India
National Diabetes Obesity and Cholesterol Foundation

Completed

Pre-meal Load of Raw Almonds and Postprandial Hyperglycemia

Intervention

India
Diabetes Foundation, India
National Diabetes Obesity and Cholesterol Foundation

Recruiting

Correlation of Xanthelasma With Atherosclerosis, Hepatic Fat and Fibrosis

Type2diabetes

India
Diabetes Foundation, India
National Diabetes Obesity and Cholesterol Foundation

Recruiting

To Identify Anytime Hyperglycaemia in Subjects With Normoglycaemia and Prediabetes

Healthy

India
Diabetes Foundation, India
National Diabetes Obesity and Cholesterol Foundation

Completed

Effects of Metformin Therapy on Pancreatic and Hepatic Fat Content in Patients of Type 2 Diabetes Mellitus

Type2diabetes

India
S. Andrea Hospital
Italian Multiple Sclerosis Foundation

Completed

Interferon ß-1b Treatment by Cyclical Administration

Multiple Sclerosis

Italy
Italian Network for Tumor Biotherapy Foundation
AstraZeneca

Unknown

A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)

Peritoneal Mesothelioma | Pleural Mesothelioma

Italy
Joslin Diabetes Center
Juvenile Diabetes Research Foundation

Completed

Effect of Gain on Closed-Loop Insulin

Type 1 Diabetes

United States
University of Alberta
Juvenile Diabetes Research Foundation; Diabetes Research Institute Foundation; Alberta Diabetes Institute and other collaborators

Active, not recruiting

PolyTreg Immunotherapy in Islet Transplantation

Diabetes | Diabetes Mellitus, Type 1

Canada
Diabetic Nephropathy Study Group
Italian Society of Diabetology

Completed

Renal Insufficiency And Cardiovascular Events (RIACE)

Cardiovascular Disease

Italy
Sansum Diabetes Research Institute
Juvenile Diabetes Research Foundation

Completed

Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind Corp

Type 1 Diabetes Mellitus

United States
Steno Diabetes Center Copenhagen
Juvenile Diabetes Research Foundation

Unknown

GABA Treatment in Subjects With Type 1 Diabetes (GABA-1)

Type 1 Diabetes Mellitus

Denmark
Steno Diabetes Center Copenhagen
Juvenile Diabetes Research Foundation; Oeresund Diabetes Academy

Completed

Anti-Interleukin-1 in Diabetes Action (AIDA)

Type 1 Diabetes

Spain, Denmark, Netherlands, Germany, Italy, Poland, Switzerland
GlaxoSmithKline
Juvenile Diabetes Research Foundation

Terminated

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM) (TTEDD)

Diabetes Mellitus, Type 1

United States, Canada
GlaxoSmithKline
Juvenile Diabetes Research Foundation

Completed

Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2 (DEFEND-2)

Diabetes Mellitus, Type 1

Italy
Diabetes Foundation, India
Johns Hopkins University; National Diabetes Obesity and Cholesterol Foundation

Recruiting

Use of AI in Cardiometabolic Risk Prediction in Asian Indians

Type2diabetes

India
Isala
Dutch Diabetes Research Foundation

Completed

Effect of Hemodialysis on Toe Pressure- and Finger Pressure and Skin Autofluorescence in Hemodialysis Patients

End Stage Renal Disease
CoMentis
Juvenile Diabetes Research Foundation

Completed

Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)

Diabetic Macular Edema

United States
Antea Foundation
Abbott Diabetes Care

Active, not recruiting

GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.

Diabetes Mellitus, Type 2 | Diabetes | Cancer | Diabetes Mellitus, Type 1 | Advanced Cancer | Palliative Care | Terminal Illness | End Stage Cancer | Terminal Cancer

Israel, Italy, Switzerland
AstraZeneca
Juvenile Diabetes Research Foundation

Completed

Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

United States
GlaxoSmithKline
Juvenile Diabetes Research Foundation

Completed

Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1 (DEFEND-1)

Diabetes Mellitus, Type 1

United States, Finland, Sweden, Italy, Spain, United Kingdom, Germany, Canada, Denmark
AstraZeneca
Juvenile Diabetes Research Foundation

Completed

Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM

Type 1 Diabetes

United States
India Diabetes Research Foundation & Dr. A. Ramachandran...

Unknown

Secular Trends in the Prevalence of Cardiometabolic Risk Factors Among Teenage School Children in Urban South India

Hypertension | Obesity | Insulin Resistance | Dyslipidemias | Dysglycemia

India
India Diabetes Research Foundation & Dr. A. Ramachandran...

Unknown

The Severity of COVID 19 in Diabetes and Non-diabetes Patients (COVID19)

Covid19 | Type2 Diabetes

India
India Diabetes Research Foundation & Dr. A. Ramachandran...

Withdrawn

Sitagliptin in Prevention of Type 2 Diabetes Mellitus (SITAGLIPTIN)

Type 2 Diabetes

India
India Diabetes Research Foundation & Dr. A. Ramachandran...

Completed

Secular Trends in the Prevalence of Diabetes in India (STRiDE-I)

PreDiabetes | Type2 Diabetes

India
India Diabetes Research Foundation & Dr. A. Ramachandran...

Completed

A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus

TYpe 2 Diabetes Mellitus

India
Diabetes Foundation, India
Almond Board of California; National Diabetes Obesity and Cholesterol Foundation

Recruiting

Almonds and Cognitive Functions

PreDiabetes

India
India Diabetes Research Foundation & Dr. A. Ramachandran...

Completed

Study of Association of Salivary Adipokines With Prediabetes and Type 2 Diabetes Mellitus

Type2 Diabetes Mellitus
India Diabetes Research Foundation & Dr. A. Ramachandran...

Completed

A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes Patients

Type2 Diabetes

India
India Diabetes Research Foundation & Dr. A. Ramachandran...

Completed

Effectiveness of Automated Mobile Phone Based Text Messaging on the Improvement of Glycaemic Outcomes

Type 2 Diabetes Mellitus

India

Clinical Trials Sponsored by Italian Diabetes Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations